While DNMT1 knockout mutations did exhibit stronger effects in some AML cell lines screened compared to others, we were unable to determine if DNMT1 is synthetic lethal with DNMT3A mutational status in these cell lines. The gene discussed is DNMT1; the disease is acute myeloid leukemia.